Caveolin-1 genotypes as predictor for locoregional recurrence and contralateral disease in breast cancer.
Christopher GodinaHelga TryggvadottirAna BoschSigne BorgquistMattias BeltingKarolin IsakssonHelena JernströmPublished in: Breast cancer research and treatment (2023)
CAV1 polymorphisms were associated with increased risk for locoregional recurrence and contralateral breast cancer. These findings may identify patients that could derive benefit from more tailored treatment to prevent non-distant events, if confirmed.